Kasama Tsuyoshi, Ohtsuka Kumiko, Sato Michihito, Takahashi Ryo, Wakabayashi Kuninobu, Kobayashi Kazuo
Division of Rheumatology, Department of Medicine, School of Medicine, Showa University, Tokyo 142-8666, Japan.
Arthritis. 2010;2010:106202. doi: 10.1155/2010/106202. Epub 2010 Dec 26.
Macrophage migration inhibitory factor (MIF) was originally identified in the culture medium of activated T lymphocytes as a soluble factor that inhibited the random migration of macrophages. MIF is now recognized to be a multipotent cytokine involved in the regulation of immune and inflammatory responses. Moreover, the pivotal nature of its involvement highlights the importance of MIF to the pathogenesis of various inflammatory disorders and suggests that blocking MIF may be a useful therapeutic strategy for treating these diseases. This paper discusses the function and expressional regulation of MIF in several rheumatic diseases and related conditions.
巨噬细胞移动抑制因子(MIF)最初是在活化T淋巴细胞的培养基中作为一种抑制巨噬细胞随机移动的可溶性因子被鉴定出来的。现在人们认识到MIF是一种多效性细胞因子,参与免疫和炎症反应的调节。此外,其参与的关键性质突出了MIF在各种炎症性疾病发病机制中的重要性,并表明阻断MIF可能是治疗这些疾病的一种有用的治疗策略。本文讨论了MIF在几种风湿性疾病及相关病症中的功能和表达调控。